Co-Diagnostics Announces Updated Third Quarter 2026 Earnings Release Date and Webcast
SALT LAKE CITY, Nov. 5, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it will release its third quarter 2026...


